🇨🇦 somatropin - GH naïve pediatric cohort in Canada

somatropin - GH naïve pediatric cohort (somatropin-gh-na-ve-pediatric-cohort) regulatory status in Canada.

Marketing authorisation

somatropin - GH naïve pediatric cohort in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is somatropin - GH naïve pediatric cohort approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for somatropin - GH naïve pediatric cohort in Canada?

Pfizer Inc. is the originator. The local marketing authorisation holder may differ — check the official source linked above.